StateHouse Holdings Inc. (STHZF)
StateHouse Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $35,601. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of -49.6%. Its beta of 1.84 implies it has historically moved more than the broad market.
StateHouse Holdings Inc. operates as a vertically integrated enterprise within the U.S. cannabis sector, encompassing cultivation, processing, manufacturing, distribution, and direct retail sales of its products. The company caters to both the adult recreational and medical cannabis markets. Its retail network comprises 13 dispensaries throughout California, along with one location in Oregon, including a notable outlet situated in San Francisco's iconic Haight Ashbury district. This organization, previously known as Harborside Inc., rebranded to StateHouse Holdings Inc. in July 2022. Its corporate headquarters are located in San Diego, California.
StateHouse Holdings Inc. is most often compared with the following Healthcare names: